Recently, the Guangzhou Municipal Administration for Market Regulation issued a notice on the cancellation of Cosmetics Manufacturing Licenses. Among the companies listed for cancellation was Guangzhou Xiandi Biotechnology Co., Ltd., with the remarks column stating that the “enterprise voluntarily applied for cancellation.”
On March 10, Shenzhen Sanda Cosmetics Co., Ltd. (hereinafter referred to as “Sanda Co., Ltd.”), the controlling company of Guangzhou Xiandi Biotechnology Co., Ltd., released a Public Notice on the Adjustment of the Production Entity of the Guangzhou Factory in response to the cancellation of the cosmetics manufacturing license of Guangzhou Xiandi Biotechnology Co., Ltd.
According to the notice, Guangzhou Xiandi Biotechnology Co., Ltd. is currently fully responsible for the overall operation and management of the Guangzhou Industrial Park. The cosmetics manufacturing business previously handled by Guangzhou Xiandi Biotechnology Co., Ltd. has now been taken over by Guangzhou Meichuang Benyuan Biotechnology Co., Ltd., another company controlled by Xiandi. The company has completed the voluntary cancellation of the cosmetics manufacturing license of Guangzhou Xiandi Biotechnology Co., Ltd. and obtained the relevant cosmetics production licenses for Guangzhou Meichuang Benyuan Biotechnology Co., Ltd. The production address, core technologies, and management team remain unchanged, while the production scale, quality standards, and supply chain system continue to operate in a stable and seamless manner.
In addition, according to media reports, Sanda Co., Ltd. publicly stated that it has received investment from a leading enterprise. The adjustment of the production entity for the Guangzhou factory is intended to further optimize the company’s industrial layout, and related production and operational activities are progressing as planned.
Public information shows that Sanda Co., Ltd. is the core entity of Hong Kong Xiandi Group. Founded in Shenzhen in 2001, the company focuses on cosmetics R&D, manufacturing, brand operations, and omni-channel sales. It owns several well-known skincare brands, including GOBEN, RIBECS, and STENDERSYA.
In 2019, Sanda Co., Ltd. completed IPO tutoring filing with the Shenzhen Securities Regulatory Bureau. On July 3, 2020, the Shenzhen Stock Exchange officially accepted Xiandi’s application for an IPO on the ChiNext board. However, in December 2020, Sanda Co., Ltd. submitted an application to withdraw its ChiNext IPO.
According to its previously disclosed prospectus, Sanda Co., Ltd. recorded revenues of RMB 499 million, RMB 693 million, RMB 747 million, and RMB 290 million in 2017, 2018, 2019, and the first half of 2020, respectively. Net profits attributable to shareholders during the same periods were RMB 51.06 million, RMB 77.83 million, RMB 109 million, and RMB 43.06 million.
